Xoma (XOM) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
28 Aug, 2025Executive summary
Strategic focus shifted to FLOW, a biological water purification technology using microalgae, with other projects paused or ended to concentrate resources and maximize value creation.
FLOW targets industrial clients facing stricter environmental regulations, offering a scalable, sustainable, and cost-effective alternative to traditional methods.
Recent management change with Mourad Lahdo appointed as CEO in June 2025.
Financial highlights
Q2 2025 operating income was 0.204 MSEK, up from 0 MSEK in Q2 2024, reflecting capitalized development work.
EBITDA for Q2 2025 was -2.263 MSEK (Q2 2024: -0.351 MSEK); EBIT was -2.293 MSEK (Q2 2024: -0.381 MSEK).
Net result after financial items for Q2 2025 was -2.294 MSEK (Q2 2024: -0.382 MSEK); EPS improved to -0.04 SEK from -0.06 SEK.
For H1 2025, operating income was 0.347 MSEK (H1 2024: 0 MSEK); EBITDA -3.468 MSEK (H1 2024: -0.497 MSEK); EBIT -3.529 MSEK (H1 2024: -0.557 MSEK); EPS -0.05 SEK (H1 2024: -0.09 SEK).
Q2 results included one-time costs: 0.73 MSEK for the rights issue and 0.138 MSEK for previous CEO compensation.
Outlook and guidance
Strategic focus on FLOW as the main business area, with all other guidance and targets withdrawn.
Emphasis on building early-stage project volume and strengthening industrial partnerships.
Latest events from Xoma
- FLOW technology advanced toward commercialization, with strengthened finances despite higher losses.XOM
Q4 202518 Feb 2026 - FLOW's technical breakthrough and strong capital base position for growth in water treatment.XOM
Q3 202527 Nov 2025 - New partnerships and financing drive Xoma's growth amid rising development costs.XOM
Q1 20256 Jun 2025 - Direct listing and FLOW launch mark Xoma's shift to growth in algae and water tech.XOM
Q4 20246 Jun 2025